More than three out of every five Americans (62%) have at least one pet in their home, this number is even higher among younger individuals, indicating a growing trend.
Currently, 95% of pet owners consider their pets as beloved family members, deserving the same level of care also in terms of health. Dogs, also known as “man’s best friend”, often face various health conditions that can greatly impact their quality of life, such as atopic dermatitis or even certain types of cancer. Unfortunately, these conditions are not always adequately addressed.
At Nanogrow, we firmly believe that immunotherapy using stabilized nanoantibodies is an appealing approach in such cases. This innovative treatment option offers several benefits, including cost-effectiveness and proven efficacy in addressing similar diseases in humans.